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Trypanosoma brucei undergoes complex metabolic and mor-
phological changes during its life cycle in order to adapt and
survive inside the mammalian host and the tsetse fly vector. One
of these adaptations to different environments is reflected by the
expression of various nucleoside transporters. As protozoan par-
asites are unable to synthesise the purine ring de novo, they have
to salvage preformed nucleosides and nucleobases from their
hosts [1]. To date, several nucleoside transporters of T. brucei
have been identified and characterised, all of which belong to the
equilibrative nucleoside transporter family. Depending on their
substrate specificities they can be assigned to two types of trans-
port activities, P1 and P2 [2]. P1 activity is specific for the uptake
of adenosine, guanosine and inosine and has been found in
both bloodstream and procyclic forms. P2 activity is specific for
adenosine and adenine uptake. Only one P2 transporter, TbAT1,
has been described so far. TbAT1 is expressed in bloodstream
forms and has been shown to transport the trypanocidal drugs
melarsoprol and pentamidine [2,3]. Additionally, purines can
be salvaged by the hypoxanthine transporting activities H1–H4
[4,5].
Although many nucleoside transporters and their substrate
specificities have been characterised, the reason for the parasite
to employ many related transporters with the seemingly redun-
dant function of purine uptake, is still unclear. Furthermore, very
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little is known about the contribution of single transporters to
purine uptake in different life cycle stages of the parasite.
The nucleoside transporterTbNT10 [6] (Tb09.160.5480, also
known as TbAT-B [7]), displays a P1-type transport activity
with high affinities for adenosine, guanosine and inosine and
marginal affinities for hypoxanthine and adenine [6,7]. TbNT10
mRNA was shown to be stage-regulated in T. brucei rhode-
siense EATRO 2340, with highest expression in short stumpy
bloodstream forms and lowest expression in long slender blood-
stream and procyclic forms [6]. This regulated expression during
the life cycle might point to a function of the transporter in the
process of differentiation.
In this study a possible role of TbNT10 in differentiation
from long slender to short stumpy bloodstream forms, and in
the following differentiation step to procyclic forms, was inves-
tigated. Northern blot analysis with mRNA from different life
cycle stages of T. brucei brucei strain AnTat 1.1 [8,9] confirmed
that theTbNT10mRNA is expressed at a low level in long slender
bloodstream forms and is up-regulated in short stumpy blood-
stream forms (Fig. 1A). In this strain, however, the highest level
of TbNT10 mRNA was found in procyclic forms. Strain-specific
differences have been observed previously for the expression of
another P1-type transporter TbNT2 [10]. In addition, culture
conditions might influence expression levels of certain trans-
porters. The TbNT10 mRNA is 4.2 kb long, with an open reading
frame (ORF) of 1.4 kb. In order to determine the length of the
untranslated regions (UTRs) a cDNA library [11] was screened
and cDNAs containing spliced leader sequences were analysed.
The 5′ UTR was found to be 42 bases. We could not determine
the precise length of the 3′ UTR, as this region contains several
0166-6851/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
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Fig. 1. TbNT10 mRNA expression and role in differentiation. (A) Northern blot analysis with 10g total RNA from long slender (LS) and short stumpy (SS)
bloodstream forms, and early (P+) and late (P−) procyclic forms of AnTat 1.1 wild type (wt) and the TbNT10 null mutant (ko). The complete ORF of TbNT10 was
amplified from genomic DNA by PCR with the primers NT10-orf1 5′-ATGCTCGGGTTTGAGTCGTT-3′ and NT10-orf2 5′-TTATGATTCTGGAAGAGCCG-3′ and
used as template to synthesise a 32P-labelled probe for hybridisation. The size of the TbNT10 mRNA reported in the original publication [6] was incorrect, this being
due to a misunderstanding between the two laboratories involved. The correct size of the transcript has been independently confirmed as being ∼4.2 kb (K. Matthews,
unpublished data). The signals were normalised using a 32P-dATP end-labelled probe specific for 18S rRNA [17]. The TbNT10 null mutant was constructed in
early procyclic forms of Trypanosoma brucei AnTat 1.1 by sequentially replacing the ORFs by a neomycin- and a hygromycin-resistance cassette, respectively.
The 5′- and 3′-flanking regions of the ORF were amplified by PCR using the primers: NT10-KpnI 5′-CAGGTACCAAACTGACGAAAGTGC-3′, NT10-HindIII 5′-
GGAAGCTTCTTGCTTAAATGACTCAG-3′, NT10-BamHI 5′-TTGGATCCCTAAGAGGAGGTAA-3′ and NT10-XbaI 5′-TATCTAGACACATTTGTGGGCGCG-
3′. The products were cloned into pBluescript upstream and downstream of a neomycin- or a hygromycin-resistance gene, respectively, using the restriction sites
(underlined) introduced by the primers. Stable transformation was performed as described [18]. Inserts were excised by digestion with KpnI and XbaI prior to
electroporation. (B) In vitro differentiation from long slender to short stumpy bloodstream forms. Long slender bloodstream forms of the TbNT10 null mutant and the
wild type were thawed from frozen mouse blood stabilates and cultured with a starting density of 3 × 104 cells/ml in HMI-9 medium containing 0.65% low melting
temperature agarose and 10% horse serum. The 1 mM inosine was added to wild-type cells where indicated (wt ino). After 0, 24, 48, and 72 h of incubation at 37 ◦C
and 5% CO2 the percentage of long slender, intermediate and short stumpy forms was determined by the diaphorase assay [14]. A representative experiment (from
four independent experiments with similar results) is shown. Growth of the cells was monitored during differentiation and the means of three experiments ± standard
deviation (S.D.) are shown. (C) In vivo differentiation from long slender to short stumpy bloodstream forms. Four MF1 mice were infected with bloodstream forms
of wild type or TbNT10 null mutant parasites, respectively. Parasitaemia was measured every 24 h from day 3 until day 10 post infection and the means ± S.D. are
shown (two out of four mice infected with wild-type parasites died on day 9 of the experiment). At the same time points, cell division was monitored by DAPI
staining and microscopic analysis of the numbers of nuclei (N) and kinetoplasts (K) per cell. The proportion of cells with 1K1N (comprising cells arrested in G1/G0
as well as proliferative cells early in their cell cycle) and dividing (2K1N, 2K2N) cells are shown. (D) The in vivo differentiation of the parasites described above was
monitored by microscopic analysis of the morphology; 250 cells were analysed per sample and categorised as long slender, intermediate or short stumpy bloodstream
forms. Data points represent the parasite populations in individual mice infected with the wild type (wt1, wt2) and the null mutant (ko1, ko2).
AU-rich stretches that supported internal priming. Considering
the Northern blot data, however, we estimate the 3′ UTR to be
∼2.7 kb long.
As mentioned above, the regulated expression of TbNT10
mRNA could point to several functions in the differentiation
from long slender to short stumpy bloodstream forms. Short
stumpy forms are pre-adapted to be taken up by the tsetse fly.
They are unable to divide in the mammalian bloodstream and
die within a few days. The differentiation from long slender into
short stumpy bloodstream forms is triggered by a stumpy induc-
ing factor (SIF) that accumulates in a cell-density dependent
manner in culture medium (and presumably blood) containing
long slender parasites [12]. SIF has been characterised as a small
compound with a molecular weight of ≤500 Da. Its chemical
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identity is still unclear, but it could potentially be a nucleoside
since membrane permeable cAMP analogues mimic SIF activity
[12].
In order to investigate the role of TbNT10 in the response to
SIF, a null mutant (Δnt10::NEO/Δnt10::HYG) was constructed
in T. brucei AnTat 1.1 (Fig. 1A). For technical reasons, this was
done in procyclic forms, as these are considerably easier to trans-
fect. Southern blot analysis confirmed the correct integration of
the two antibiotic resistance cassettes into the TbNT10 loci (data
not shown) and Northern blot analysis confirmed the absence of
TbNT10 mRNA in the null mutant (Fig. 1A). Early procyclic
forms of the null mutant showed no phenotype in growth or in
differentiation from early to late procyclic forms, as assessed
by the loss of GPEET procyclin [13] (data not shown). Fur-
thermore, the null mutant was still able to infect tsetse flies
(Glossina morsitans morsitans), and subsequently mice, from
which long slender bloodstream forms were isolated for further
analysis. In order to test whether TbNT10 is required for dif-
ferentiation from the long slender to short stumpy bloodstream
form, cultures of the wild type and the TbNT10 null mutant
were compared (Fig. 1B). Differentiation to the stumpy form
was monitored by the diaphorase assay [14]. The null mutant
entered stationary phase at a lower cell density, but differenti-
ated to the short stumpy bloodstream form as fast as the wild
type. To determine if SIF might be taken up by other P1 trans-
porters, wild-type cells were cultured in the presence of 1 mM
inosine, which is a P1 substrate and, hypothetically, could com-
pete with SIF (Fig. 1B). However, wild-type cells exposed to
inosine were able to differentiate from long slender to short
stumpy bloodstream forms as well as cells without the com-
petitor. These results indicate that neither TbNT10, nor any
other P1 transporter, is responsible for the uptake of SIF in
cell culture. In addition, a function of TbNT10 in the mainte-
nance of short stumpy forms or the differentiation to procyclic
forms could be excluded, as stumpy forms of the null mutant
were still able to differentiate to procyclic forms and express
EP procyclins with identical kinetics to the wild type (data not
shown).
The situation in vivo was analysed by comparing mice
infected with the TbNT10 null mutant and the wild type. Total
parasitaemia, the proportion of dividing and non-dividing cells
and differentiation from long slender to short stumpy blood-
stream forms were compared between the two groups (Fig. 1C,
D). The null mutant parasites established a peak parasitaemia
similar to the wild type, but showed a two-fold lower cell density
6–10 days post infection. However, the ratio between dividing
and non-dividing cells (Fig. 1C) and the kinetics of differen-
tiation into growth-arrested short stumpy bloodstream forms
(Fig. 1D) were the same as for wild-type cells. These data
confirmed the findings in vitro that TbNT10 is not involved
in the differentiation of long slender to short stumpy blood-
stream forms. The lower parasite density during differentiation
to short stumpy bloodstream forms in vivo as well as in vitro
might point to a shortage of purines in the TbNT10 null mutant.
Nevertheless,TbNT10 is not an essential gene, as the null mutant
could be transmitted by tsetse flies and complete the entire life
cycle.
An ectopically expressed GFP-TbNT10 fusion protein
showed a surface localisation in procyclic forms (Fig. 2A).
Taken together with the high expression of TbNT10 mRNA
in early and late procyclic forms (Fig. 1A), this points to a
likely function for the transporter in the insect stages of the
parasite, with the up-regulation of mRNA in stumpy forms
perhaps being a pre-adaptation for this. So far, two P1-type
nucleoside transport activities TbNT2 and TbNT5 [10] have
been described for procyclic forms and TbNT10 might also
contribute to the uptake of purines and purine analogues. As
a first step we measured the sensitivity to two toxic adeno-
sine analogues, tubercidin (7-deazaadenosine) and cordycepin
(3′-deoxyadenosine). The IC50 values of procyclic forms for
tubercidin and cordycepin were found to be in the M range,
which is approximately 1000-fold higher than described for
bloodstream forms [15]. In the drug sensitivity assays, pro-
cyclic forms of the null mutant were found to be 3.6 times more
resistant to both tubercidin and cordycepin compared to wild-
type parasites (Fig. 2C). In contrast, there was no difference
between the wild type and TbNT10 null mutant in their sensi-
tivity to the two trypanocidal drugs, that are taken up by the
P2 transporter TbAT1 in bloodstream forms [2,16], melarsen
oxide and pentamidine (data not shown). To confirm that the
increased resistance to tubercidin and cordycepin was due to the
depletion of TbNT10, two independent addback clones were
constructed (Fig. 2B and C). The TbNT10 mRNA levels in
both clones were comparable to that of the endogenous tran-
script, as shown by Northern blot (Fig. 2B). Ectopic expression
of TbNT10 not only restored the sensitivity to tubercidin, but
enhanced it up to 13-fold compared to wild-type cells. A sim-
ilar trend was found in the response to cordycepin, as the two
addback clones became approximately five-fold more sensitive
than wild-type cells. In order to determine the contribution of
TbNT10 to total P1-type purine uptake, two substrates, inosine
and adenosine, were added to the drug assays as competitors
(Fig. 2C). An excess of competitor (1 mM) increased drug resis-
tance in all cell types, except the null mutant. The addition
of competitors did not substantially increase the resistance of
the wild type above that of the null mutant (without competi-
tors); however, indicating that most P1-type transport was due
to TbNT10.
Although the addbacks became more resistant to tubercidin
in the presence of either competitor, they did not reach the same
level of resistance as the wild type, possibly because the trans-
porters were not saturated. Unexpectedly, however, they became
highly resistant to cordycepin in the presence of adenosine. This
could reflect the mode of action of cordycepin which, unlike
tubercidin, is able to compete with adenosine intracellularly
for integration into nucleic acids. Alternatively, this could be
a consequence of different affinities of TbNT10 for the various
substrates. Another unexpected finding was that the null mutant
became more sensitive to cordycepin when competitors, partic-
ularly adenosine, were added. A similar outcome was recently
reported for a TbAT1 null mutant in bloodstream forms that
became hypersensitive to cordycepin in the presence of adenine
[15]. One possibility is that crosstalk between different trans-
porters might be involved in this effect, as other transporters
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Fig. 2. (A) Localisation of a GFP-TbNT10 fusion protein. The TbNT10 ORF was cloned into the BamHI site of the vector pG-EGFP-LII [18] downstream
of the GFP ORF. The construct was transiently transfected into AnTat 1.1 procyclic forms and expression of the GFP-TbNT10 fusion protein was analysed after
24 h by confocal microscopy. Scale bar indicates 10m. (B) Construction of TbNT10 addback mutants. The ORF of TbNT10 was cloned into the EcoRI site of
pGAPRONE-LII containing a puromycin resistance cassette [19]. The insert was excised using KpnI and NotI and stably transfected into early procyclic forms of
the TbNT10 null mutant. Two independent addback clones were analysed for correct integration into an EP procyclin locus. About 10g total mRNA of the wild
type (wt), the null mutant (ko) and the two addback clones (A and B) were subjected to Northern blot analysis as described above. The relative amounts of TbNT10
mRNA are indicated under each lane. (C) Sensitivity to toxic adenosine analogues. IC50 values of the wild type, the null mutant and the addback clones for tubercidin
and cordycepin were determined by Alamar blue assays [15]. The assays were carried out without competitor (empty bars) or in the presence of 1 mM inosine (ino)
or 1 mM adenosine (ado), respectively, as indicated (filled bars). The means ± S.D. from at least five experiments are shown for each cell line. (D) Uptake assays with
3H-labelled adenosine were performed with wild type, null mutant and addback clone A, as described [20]. One out of eight experiments with comparable results is
shown.
could be up-regulated in the null mutant and might also con-
tribute to drug uptake. Thus, although we cannot explain all
effects observed in the drug assays, they clearly show a signifi-
cant contribution by TbNT10 in the uptake of purine analogues
by procyclic forms of T. brucei.
In order to quantify the contribution of TbNT10, the rates
of adenosine uptake were compared in the wild type, the null
mutant and one addback clone (Fig. 2D). Wild type cells showed
strong adenosine uptake in the range of 50 pmol/107 cells
after 5 min. Consistent with the results from the drug sensi-
tivity assays, adenosine uptake by the addback mutant was
increased to 70 pmol/107 cells, while uptake by the TbNT10 null
mutant never exceeded 10 pmol/107 cells after 5 min (Fig. 2D).
Once again, these results indicate a major role for TbNT10 in
adenosine uptake by procyclic forms, although the parasites
clearly have other means to acquire purines (for example, via
hypoxathine transporters).
In conclusion, the stage regulated nucleoside transporter
TbNT10 is not involved in the differentiation from long slender
to short stumpy forms or in the transition to procyclic forms.
It is not an essential gene, since null mutants can complete
the whole life cycle. Nevertheless, we have demonstrated that
in procyclic forms, where high levels of TbNT10 mRNA are
expressed, purines and toxic analogues are imported by TbNT10
and that it is the main transporter for adenosine in this life cycle
stage.
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